NDC00049-2540-66: THEOPHYLLINE,EPHEDRINE SULFATE,A.
THEOPHYLLINE,EPHEDRINE SULFATE,A. Key specifications include administration: ORAL, features_provided: ENTERIC COATED AND CHILD RESISTANT CLOSURE, primary_container_type: BOTTLE, primary_container_content_quantity: 100.000 TABLETS. This part is cataloged in the U.S.
Government catalog under NSN 6505-00-149-0114, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| features_provided | ENTERIC COATED AND CHILD RESISTANT CLOSURE |
| primary_container_type | BOTTLE |
| primary_container_content_quantity | 100.000 TABLETS |
| active_medicament_medicinal_strength | 25.000 MILLIGRAMS EPHEDRINE SULFATE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE ACTIVE INGREDIENT AND 130.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |
| NSN | 6505-00-149-0114 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| FEATURES PROVIDED | ENTERIC COATED AND CHILD RESISTANT CLOSURE |
| PRIMARY CONTAINER TYPE | BOTTLE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 25.000 MILLIGRAMS EPHEDRINE SULFATE ACTIVE INGREDIENT AND 10.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE ACTIVE INGREDIENT AND 130.000 MILLIGRAMS THEOPHYLLINE ACTIVE INGREDIENT |